FDA approves generic version of Ultram ER.
Copyright © 2009 by Custom Briefings

The AP (11/17) reports, "Par Pharmaceutical Co. said Monday it received marketing approval for a generic version of Johnson & Johnson's extended-release chronic pain drug Ultram ER, and has started shipping the drug." The FDA "approved Par's generic in doses of 100 milligrams and 200 milligrams." Reuters 11/17) also covers the story.